Immunologic diagnostic and therapeutic aspects of cytomegalovirus, human herpes virus-6, and Epstein-Barr virus disease posttransplantation.
作者信息
Jacobs U, Eis-Hübinger A, Dietrich Miersch W, Klehr H U
机构信息
Department of General Internal Medicine, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany.
出版信息
Transplant Proc. 1996 Dec;28(6):3238.
PMID:8962253
Abstract
摘要
相似文献
1
2
Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation.肾移植后使用更昔洛韦和巨细胞病毒高免疫球蛋白成功治疗爱泼斯坦-巴尔病毒感染。
Transplant Proc. 1995 Oct;27(5 Suppl 1):58-9.
3
Viral infections in renal transplant recipients: an evolutionary problem.肾移植受者中的病毒感染：一个进化问题。
Adv Nephrol Necker Hosp. 1986;15:353-78.
4
Immunological aspects of a case of posttransplant lymphoproliferative disorder.
Am J Nephrol. 1995;15(2):137-41. doi: 10.1159/000168818.
5
6
Treatment of cytomegalovirus infections with gancyclovir during OKT3 administration.
Transplant Proc. 1995 Oct;27(5):2707.
7
Incidence of cytomegalovirus infection in kidney recipients.
Transplant Proc. 1996 Aug;28(4):2314-5.
8
Diagnosis of viral infections under therapy with OKT3 and antithymocyte globulin.
Transplant Proc. 1992 Dec;24(6):2636-8.
9
10
[The diagnostic value of Epstein-Barr virus diagnosis].[爱泼斯坦-巴尔病毒诊断的诊断价值]
Internist (Berl). 1992 Sep;33(9):586-92.
引用本文的文献
1
A Drug Safety Briefing (II) in Transplantation from Real-World Individual Pharmacotherapy Management to Prevent Patient and Graft from Polypharmacy Risks at the Very Earliest Stage.药物安全简报（II）：从真实世界的个体化药物治疗管理到尽早预防患者和移植物多重用药风险的移植领域
Pharmaceuticals (Basel). 2024 Feb 25;17(3):294. doi: 10.3390/ph17030294.
2
A Drug Safety Concept (I) to Avoid Polypharmacy Risks in Transplantation by Individual Pharmacotherapy Management in Therapeutic Drug Monitoring of Immunosuppressants.一种药物安全理念（一）：通过免疫抑制剂治疗药物监测中的个体化药物治疗管理避免移植中的多重用药风险
Pharmaceutics. 2023 Sep 10;15(9):2300. doi: 10.3390/pharmaceutics15092300.
Zotero 插件